Peptide drugs that target local inflammation and angiogenesis demonstrate reduced lesion size in animal models and early human safety data
All tissue procured has been screened by using Chagas enzyme immunoassay (EIA) test antibodies to the human immunodeficiency virus, type 1 and type 2 (anti-HIV-1 and anti-HIV-2) Plus O, Nucleic Acid Test (NAT) for HIV-1, hepatitis B surface antigen (HbsAg), hepatitis B, core total Ab, hepatitis C virus Ab (anti-HCV), cytomegalovirus (CMV) total Ab, HTLV I/II Ab, West Nile virus (WNV), ZIKA NAT, Nucleic Acid Test (NAT) for the hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HBV/HCV), syphilis, and Lyme disease
Singleton VL, Orthofer R, Lamuela-Raventos RM
Composition of Gsh Glutathione Bulking agent (microcrystalline cellulose (cellulose gel)), Reduced L-glutathione, Capsule wall (cellulose (HPMC)), Anti-caking agent (magnesium stearate)